中国全科医学 ›› 2016, Vol. 19 ›› Issue (31): 3812-3816.DOI: 10.3969/j.issn.1007-9572.2016.31.011

• • 上一篇    下一篇

马来酸依那普利叶酸片对H型高血压患者血栓前状态的影响研究

宋志芳,郑泽琪   

  1. 330006 江西省南昌市,南昌大学第一附属医院心血管内科,江西省高血压病研究所 通信作者:宋志芳,330006 江西省南昌市,南昌大学第一附属医院心血管内科,江西省高血压病研究所;E-mail:szfmm@163.com
  • 出版日期:2016-11-05 发布日期:2026-01-26

Impact of Enalapril Maleate Folic Acid Tablets on Prethrombotic State in Patients with H-type Hypertension

SONG Z F,ZHENG Z Q   

  1. Department of Cardiology,the First Affiliated Hospital of Nanchang University;Institute of Hypertension of Jiangxi,Nanchang 330006,China Corresponding author:SONG Zhi-fang,Department of Cardiology,the First Affiliated Hospital of Nanchang University;Institute of Hypertension of Jiangxi,Nanchang 330006,China;E-mail:szfmm@163.com
  • Published:2016-11-05 Online:2026-01-26

摘要: 目的 探讨马来酸依那普利叶酸片对H型高血压患者血栓前状态的影响。方法 于2014年6月—2015年9月选取在南昌大学第一附属医院就诊的高血压1级患者126例。根据血清同型半胱氨酸(Hcy)水平,将纳入患者分为单纯高血压组(Hcy0.05);治疗后试验组患者CD62p、CD63、vWF、Fg、TXB2、PAI-1低于对照组,t-PA高于对照组,差异有统计学意义(P0.05)。结论 H型高血压患者存在更为严重的血栓前状态,马来酸依那普利叶酸片在有效降低H型高血压患者血压的同时,可以改善患者的血栓前状态,有助于防止心脑血管事件的发生。

关键词: 高血压, 高同种半胱氨酸血症, 依那普利, 叶酸, 血栓前状态

Abstract: Objective To investigate the impact of enalapril maleate folic acid tablets on prethrombotic state in patients with H-type hypertension.Methods From June 2014 to September 2015,126 level-one hypertension patients who received treatment in the First Affiliated Hospital of Nanchang University were selected.According to the serum homocysteine(Hcy) levels,the included subjects were divided into simple hypertension group(Hcy<10 μmol/L,n=35) and H-type hypertension group(Hcy≥10 μmol/L,n=91);H-type hypertension patients were divided into control group(n=46) and experiment group(n=45) by random number table method.Patients in simple hypertension group and control group were treated with enalapril maleate tablets orally,patients in experiment group were treated with enalapril maleate folic acid tablets orally,and both of them took continuously for six months.Results The platelet a granule membrane glycoprotein(CD62p),platelet lysosome membrane protein(CD63),von willebrand factor(vWF),fibrinogen(Fg),thromboxane B2(TXB2),plasminogen activator inhibitor-1(PAI-1) of patients in H-type hypertension group were significantly higher than those in simple hypertension group,and its tissue-type plasminogen activator(t-PA) was significantly lower(P<0.05).The comparison of CD62p,CD63,vWF,Fg,TXB2,t-PA and PAI-1 between patients in control group and experiment group before treatment was not significantly different(P>0.05);CD62p,CD63,vWF,Fg,TXB2,and PAI-1 of patients after treatment in experiment group were significantly lower than those in control group,while t-PA was significantly higher(P<0.05).After treatment,CD62p,CD63,vWF,Fg,TXB2,and PAI-1 of patients in experiment group were significantly lower than those before treatment,while t-PA was significantly higher(P<0.05);while CD62p,CD63,vWF,Fg,TXB2,t-PA,and PAI-1 of patients in control group compared with those of patients before treatment were not significantly different(P>0.05).Conclusion H-type hypertension patients have presented even more severe prothrombotic state,and enalapril maleate folic acid tablets can effectively reduce the blood pressure of H-type hypertension patients and improve their prethrombotic state at the same time,which helps prevent the occurrence of cardiovascular and cerebrovascular events.

Key words: Hypertension, Hyperhomocysteinemia, Enalapril, Folic acid, Prethrombotic state